Abstract:
A fiber panel system includes a chassis including a backplane; and at least a first blade configured to mount to the chassis. The first blade is moveable relative to the chassis between a retracted (closed) position and at least one extended position. The first blade includes a coupler arrangement for connecting together media segments. The first blade remains electrically connected to the backplane of the chassis when moving between the retracted and extended positions.
Abstract:
A fiber panel system includes a chassis and at least blades configured to mount to the chassis. Each blade is moveable relative to the chassis between a retracted (closed) position and at least one extended position. Cable slack is managed at the front and/or rear of each chassis to facilitate movement of the blades without pulling or bending the cables beyond a maximum bend limit. Each blade may be locked into one or more positions relative to the chassis.
Abstract:
A fiber panel system includes a chassis and at least a first blade configured to moveably mount to the chassis. Each blade includes a base, a frame, and front couplers. The base of each blade defines at least one opening at a location spaced rearwardly from the front couplers. The front couplers may be smart or passive.
Abstract:
A fiber panel system includes a chassis including a backplane; and at least a first blade configured to mount to the chassis. The first blade is moveable relative to the chassis between a retracted (closed) position and at least one extended position. The first blade includes a coupler arrangement for connecting together media segments. The first blade remains electrically connected to the backplane of the chassis when moving between the retracted and extended positions.
Abstract:
Methods for identifying modulators of KEAH6 are described. The methods are particularly useful for identifying analytes that antagonize KEAH6's effect on processing of amyloid precursor protein to Aß peptide and thus useful for identifying analytes that can be used for treating Alzheimer disease.
Abstract:
Methods for identifying modulators of ADPRH are described. The methods are particularly useful for identifying analytes that antagonize ADPRH 's effect on processing of amyloid precursor protein to AjS peptide and thus useful for identifying analytes that can be used for treating Alzheimer disease.
Abstract:
A method of communicating non-native print objects in MOrDCA Architecture for controlling and operating RFID writer or reader devices without requiring separate control data streams or systems to be implemented at the host computer. Data references and command identifiers are placed by application program means at the host computer into the page description data so that RFID information can be retrieved and downloaded to the printer and RFID apparatus when the print data is being processed in the print server or main processor of the printer without interfering with normal operation of the printer itself.
Abstract:
Systems and methods of identifying and processing complex text are provided. If a presentation data stream contains a complex text string, a preselected control in the presentation data stream is inserted before the complex text string. A first parameter has a value indicating a control type for controlling processing of complex text, and a second parameter takes one or more values for enabling and disabling the processing of complex text. In processing complex text, responsive to a first predetermined type of control in a presentation data stream, if the first type of complex text processing is enabled, this processing is applied to a complex text string succeeding the first predetermined type of control in the presentation data stream. The first predetermined type of control includes a first parameter represented by a corresponding value for controlling the first type of complex text processing.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research method for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.